Biotechnology and Life Science Marketing Consulting: Comprendia » Comprendia News

Comprendia Welcomes Rebecca Watson-Beattie as Business Development Manager

Mary Canady — Sun, 13 Dec 2009 23:41:23 +0000

You may have talked with or met Rebecca Watson-Beattie by now, she’s done a great job reaching out to our clients and partners. With a background in business development, sales, marketing, and science, Rebecca is a perfect addition to our team. She understands the challenges biotechnology and life sciences companies face and shares our passion to help them launch and grow. Rebecca is very organized, focused, and pleasant, and we chose her because we think she’ll really help those who work with us to thrive. Check out Rebecca’s Bio for more information, and feel free to reach out to her.

Comprendia to Present at Transitions to Industry Symposium

Mary Canady — Tue, 10 Nov 2009 01:07:02 +0000

On November 14th, Comprendia Founder Mary Canady will be presenting an overview of San Diego Biotechnology at a local symposium geared towards life science postdocs and hosted by UCSD, The Scripps Research Institute, and Burnham Institute. Dr. Canady’s career, first as a local researcher and now as a small business owner working with biotechnology companies, gives her a unique perspective on transitioning from science to business. Check out the website for more information and to register.

Comprendia Adds Social Media Capabilities

Mary Canady — Tue, 20 Oct 2009 22:09:28 +0000

If you’ve been following our Biotechnology Marketing 101 blog, you likely know that we are ‘in the know’ about social media. We’ve used it to grow our own company and the San Diego Biotechnology Network, and we’ll be featuring our work with other companies soon. Check out our Social Media Capabilities page to learn more and to get started!

80’s Movie Meets Healthcare Innovation in San Diego

Mary Canady — Mon, 19 Oct 2009 22:20:24 +0000

Our founder Mary Canady realized a lifelong dream today. She was able to combine her love of the 80’s with her love of science in a single Xconomy post, check it out! Seriously, though, the BIL:PIL event represents a ’sea change’ in how important issues such as health care will be more accessible our input as scientists and patients, and I highly suggest attending it.

Bootstrapping Biotech: SDBN’s October 29th Event

Mary Canady — Fri, 09 Oct 2009 14:29:47 +0000

If you’ve been following along with the Biotechnology Marketing 101 blog series, you know that we provide guidance for life science and biotech companies to start and grow. We’re taking this from virtual to IRL (in real life ;) at our October 29th Bootstrapping Biotech event with the San Diego Biotechnology Network. We’ve lined up some excellent speakers who will cover everything from getting funded to strategic and tactical marketing and social media for your company or products. We’ve had a lot of interest so far, even outside of San Diego, and really think that a lot of great, synergistic connections will be made at the event. Even if you don’t work at a small company, we think you’ll be able to learn and meet those who can help you make the most out of your marketing budget. As always, we’re open to feedback as to what you’d like to see–leave a comment here or on the SDBN site.

My Grandmother Out-Tweets Your Biotech

Mary Canady — Mon, 28 Sep 2009 14:46:16 +0000

Voice of San Diego’s summary of Biocom’s Sept. 23rd ‘Social Media 2.0′ panel, featuring insight and quotes from Comprendia founder Mary Canady. Discusses the Biotechnology industry’s limited use of social media.

[[Click to read.]]

WHITECOAT Strategies and Comprendia Sign Strategic Partnership Agreement to Better Target Key Opinion Leaders, Patients, and Advocates

Mary Canady — Fri, 04 Sep 2009 20:39:51 +0000

We’re very pleased to announce a strategic partnership with WHITECOAT Strategies, a Washington, DC-based public relations firm specializing in the use of new media and online video for clients with innovative science, are announcing their recently formed strategic partnership. The alliance will bring integrated video, social media, and strategic PR to life science companies for the first time, allowing them to communicate important scientific concepts more effectively. Please see the full release for more information, and we’d love to hear what you think!

BIO 2009 Spotlight: Innovation in Ireland: Merrion Pharmaceuticals

Mary Canady — Tue, 19 May 2009 10:56:46 +0000

I spent part of Monday morning in the Ireland Pavilion (#3303) talking with them about the biotechnology they’re highlighting at the BIO convention, as well as the region as well. I spoke with Jonathan O’Connell, Chief Financial Officer of Ireland’s Merrion Pharmaceuticals, about the announcement they made last week (PDF) regarding preliminary results on Orazol™, a tablet formulation of the Novartis drug Zometa®. The company acquired a unique drug delivery technology from Elan in 2004 which boosts absorption in the intestine. As a result, therapeutics that are normally given only by injection can be formulated as tablets, leading to many benefits, including safer treatment, less pain, and improved pharmaeconomics. At BIO 2009, Merrion is focused on partnering their Phase 2 compounds, and continues to develop and seek out therapeutics which are amenable to their technology, including, notably, insulin, which they are working on with Novo Nordisk. Personally, I found the technology to be very promising and I suggest that you seek them out in the Ireland Pavilion.

I also spoke with Sean Davis from Enterprise Ireland (EI), which ‘fosters’ companies like Merrion in their early development phase. Davis says that EI has been around for 35 years and currently takes on 70-80 companies per year. The EI does 5-6 months of due diligence for each company and covers R&D aspects, commercialization, and technology transfer. EI benefits from the Irish government’s commitment to promote biotechnology in the region, stemming back 20 years ago when they began to focus on education. Their goal at BIO 2009? Presenting six of their ’success stories’ from the region and partnering with US entities who realize the potential of companies who have been well-positioned for success by EI. I highly suggest visiting the Ireland Pavilion, #3303 in the exhibit hall.

San Diego Biotechnology Network to Feature Sapphire Energy at November Event

Mary Canady — Wed, 15 Oct 2008 23:20:01 +0000

The San Diego Biotechnology Network (SDBN), a new professional organization, announced its inaugural networking event will feature a meet-and-greet with Sapphire Energy, a San Diego-based green crude production company.

SDBN was formed by two local marketing professionals, Mary Canady of Comprendia, LLC and Todd Backus of Blue Horse & Trumpet to meet the need for more face–to-face networking among Biotechnology professionals in the San Diego area, via casual, bi-monthly after-work events. SDBN events will feature a local company that represents the excitement and innovation of the San Diego biotechnology industry, and will provide a venue for their team to connect with the community in a casual atmosphere. SDBN’s choice of Sapphire Energy reflects the overwhelming interest that the biotechnology community has for the company and its technology.

Sapphire Energy was founded to address the overwhelming inadequacies of current biofuel approaches. The company has built a revolutionary platform using sunlight, CO2 and microorganisms such as algae to produce renewable fuel products – gasoline, jet fuel and diesel – that meet ASTM standards. The final product is not ethanol or biodiesel. Sapphire is led by a team of entrepreneurs and experts in cell biology, plant genomics and algal production, as well as investors with long histories of taking innovative technology to market, including co-founder ARCH Venture Partners, along with the Wellcome Trust, Cascade Investment and Venrock. Sapphire’s scientific supporters include The Scripps Research Institute; University of California, San Diego; the University of Tulsa, and the Department of Energy’s Joint Genome Project. The company is located in San Diego. For more information, visit http://www.sapphireenergy.com and http://www.greencrudeproduction.com.

Contact for Sapphire Energy: Sarah Shahrabani, sarah.shahrabani@edelman.com, ph. 206.268.2228.

Event Details (RSVP Required)
Who: Sapphire Energy, Inc., and biotechnology professionals in the greater San Diego area
What: San Diego Biotechnology Network November Happy Hour
When: Tuesday, November 11th, 5:30-8:00
Where: Rock Bottom Restaurant and Brewery, La Jolla, 8980 Villa La Jolla Drive, La Jolla, CA 92037
Cost: $10
For more information about the event: http://sdbn.org, registration and confirmation required. Contact: Mary Canady, mcanady@comprendia.com, ph. 858.922.6640.

Comprendia Announces New BioStartup Marketing Kits to Facilitate Growth of Biotechnology Startup Companies

Mary Canady — Wed, 24 Sep 2008 12:22:38 +0000

SAN DIEGO, CA–(Marketwire – September 24, 2008) – Comprendia, a newly formed biotechnology and life sciences marketing consulting firm, is announcing the launch of BioStartup Marketing Kits, which will help biotechnology startups obtain the marketing they need to grow. The kits will enable the new companies to easily obtain the materials they need to launch, allowing their management to focus on other vital activities. BioStartup Marketing Kits are designed to meet the specialized needs of biotechnology companies, including materials and services such as website design, logo and branding, brochures, public relations, and social media.

This announcement comes at a time when biotechnology firms are touted as being a “safe haven” for investors during the current financial crisis. Large pharmaceutical and venture capital companies are investing in biotech companies to re-fill drug pipelines and provide novel tools for drug discovery. Additionally, the restructuring of large pharmaceutical companies has spawned a host of new drug discovery startups, founded by former big pharma employees. Choosing the right marketing strategy is essential to the success of these new, largely unknown businesses, because it not only determines their image and direction, but also their ability to raise money and recruit top scientists.

“We see a real need for science-savvy marketing solutions for small biotechnology companies,” said Mary Canady, Ph.D., Founder of Comprendia. “We understand the science that drives these companies, and can translate it into a winning marketing strategy that will lead to rapid and sustained growth for our clients. BioStartup Marketing Kits provide the materials and guide scientific entrepreneurs through a process which helps them define their objectives and message.” Dr. Canady’s insights into biotechnology marketing arise from her unique background in both science and business. She worked ten years as a biochemist and eight years in marketing and business development roles at life science and biotechnology companies, including Invitrogen and EMD/Merck Chemicals.

Comprendia, LLC, formed earlier this year, brings together Ph.D.-level scientific consultants with talented developers, designers and writers. Comprendia is located in San Diego, a biotechnology hub known for its close ties to world class research institutions such as Scripps Research Institute, Burnham Institute, and UCSD. Recently, San Diego has become home to a burgeoning green technology industry, with Sapphire Energy, Verenium, Genomatica, and Synthetic Genomics joining the biotech community. Comprendia serves the biotechnology, life sciences, and green technology industries worldwide.

For more information:
http://comprendia.com/biostartup
Mary Canady
Ph: 858.922.6640
mcanady@comprendia.com

Release on Marketwire